| Product Code: ETC6665594 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Rare Disease Genetic Testing Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Rare Disease Genetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Rare Disease Genetic Testing Market - Industry Life Cycle |
3.4 Canada Rare Disease Genetic Testing Market - Porter's Five Forces |
3.5 Canada Rare Disease Genetic Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Canada Rare Disease Genetic Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Canada Rare Disease Genetic Testing Market Revenues & Volume Share, By Specialty, 2021 & 2031F |
3.8 Canada Rare Disease Genetic Testing Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Canada Rare Disease Genetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare genetic diseases in Canada |
4.2.2 Technological advancements in genetic testing methods |
4.2.3 Growing awareness and acceptance of genetic testing for rare diseases |
4.3 Market Restraints |
4.3.1 High cost associated with genetic testing services |
4.3.2 Limited availability of specialized genetic testing laboratories in Canada |
5 Canada Rare Disease Genetic Testing Market Trends |
6 Canada Rare Disease Genetic Testing Market, By Types |
6.1 Canada Rare Disease Genetic Testing Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.1.4 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Immunological Disorders, 2021- 2031F |
6.1.5 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Hematology Diseases, 2021- 2031F |
6.1.6 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Endocrine & Metabolism Diseases, 2021- 2031F |
6.1.7 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.8 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Musculoskeletal Disorders, 2021- 2031F |
6.1.9 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Dermatology Disease, 2021- 2031F |
6.1.10 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Dermatology Disease, 2021- 2031F |
6.2 Canada Rare Disease Genetic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Next Generation Sequencing, 2021- 2031F |
6.2.3 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2.4 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.2.5 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Array Technology, 2021- 2031F |
6.2.6 Canada Rare Disease Genetic Testing Market Revenues & Volume, By PCR-based Testing, 2021- 2031F |
6.2.7 Canada Rare Disease Genetic Testing Market Revenues & Volume, By FISH, 2021- 2031F |
6.2.8 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Karyotyping, 2021- 2031F |
6.2.9 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Karyotyping, 2021- 2031F |
6.3 Canada Rare Disease Genetic Testing Market, By Specialty |
6.3.1 Overview and Analysis |
6.3.2 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Molecular Genetic Tests, 2021- 2031F |
6.3.3 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Chromosomal Genetic Tests, 2021- 2031F |
6.3.4 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Biochemical Genetic Tests, 2021- 2031F |
6.4 Canada Rare Disease Genetic Testing Market, By End use |
6.4.1 Overview and Analysis |
6.4.2 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Research Laboratories & CROs, 2021- 2031F |
6.4.3 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.4.4 Canada Rare Disease Genetic Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
7 Canada Rare Disease Genetic Testing Market Import-Export Trade Statistics |
7.1 Canada Rare Disease Genetic Testing Market Export to Major Countries |
7.2 Canada Rare Disease Genetic Testing Market Imports from Major Countries |
8 Canada Rare Disease Genetic Testing Market Key Performance Indicators |
8.1 Number of research studies published on rare genetic diseases in Canada |
8.2 Percentage of healthcare professionals recommending genetic testing for rare diseases |
8.3 Adoption rate of new genetic testing technologies in Canada |
8.4 Number of collaborations between genetic testing companies and healthcare providers in Canada |
9 Canada Rare Disease Genetic Testing Market - Opportunity Assessment |
9.1 Canada Rare Disease Genetic Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Canada Rare Disease Genetic Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Canada Rare Disease Genetic Testing Market Opportunity Assessment, By Specialty, 2021 & 2031F |
9.4 Canada Rare Disease Genetic Testing Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Canada Rare Disease Genetic Testing Market - Competitive Landscape |
10.1 Canada Rare Disease Genetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Canada Rare Disease Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here